logo

For the Inventor, By the Inventor

Providence, RI, United States of America

David B MacLean

This inventor holds 17 USPTO granted patents, primarily in Hormonal Therapies. Top assignee: Pfizer Corporation. Active years: 1998-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David B MacLean. Retrieved from https://idiyas.com/inventor/david-b-maclean

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 94.1

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 117(Granted Patents)


Location History:

  • Providence County, RI (US) (1998)
  • Groton, CT (US) (1998)
  • Providence, RI (US) (1998 - 2005)

Company Filing History:

goldMedal17 out of 4,489 
 
Pfizer Corporation
 patents

Years Active: 1998-2005

Loading Chart...
Areas of Expertise:
Estrogen Antagonists
Osteoporosis Treatment
Testosterone Increase
Autoimmune Diseases
Combination Therapy
Myocardium Protection
Myeloperoxidase Inhibition
Alzheimer's Treatment
Progesterone
Polyphosphonates
PMS Symptoms
Reperfusion Damage
17 patents (USPTO):Explore Patents
1. 6911456 - Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions (2005-06-28),
2. 6613796 - Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions (2003-09-02),
3. 6403611 - Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions (2002-06-11),
4. 6355670 - Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions (2002-03-12),
5. 6274618 - Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions (2001-08-14),
6. 6107331 - Use of estrogen antagonists and estrogen agonists in inhibiting (2000-08-22),
7. 6100301 - Combination therapy to treat osteoporosis-polyphosphonates and estrogen (2000-08-08),
8. 6057309 - Combination therapy to prevent bone loss-progesterone and estrogen (2000-05-02),
9. 6017964 - Method of increasing testosterone (2000-01-25),
10. 5985932 - Inhibition of autoimmune diseases (1999-11-16),
11. 5889042 - Method of treating diseases and conditions with estrogen agonists and (1999-03-30),
12. 5861438 - Combination therapy to prevent bone loss parathyroid hormone and (1999-01-19),
13. 5773477 - Combination therapy to treat osteoporosis - polyphosphonates and (1998-06-30),
14. 5733937 - Methods for alleviating symptoms of premenstrual syndrome and late (1998-03-31),
15. 5726207 - Protection of ischemic myocardium against reperfusion damage (1998-03-10),

Title: Innovator Spotlight: David B. MacLean

Introduction

David B. MacLean, an accomplished inventor based in Providence, Rhode Island, has made significant contributions to the field of medicine through his 17 patents. With a focus on innovative therapies, he is known for his advanced research and development in hormone-related treatments.

Latest Patents

Among his latest patents, MacLean has developed novel methods utilizing estrogen antagonists and estrogen agonists to inhibit pathological conditions tied to organ systems that react to estrogen. This invention involves administering effective amounts of specific compounds designed to provide therapeutic benefits to mammals in need of treatment.

Career Highlights

MacLean's career has been distinguished by his tenure at Pfizer Corporation, a leading pharmaceutical company where he applies his expertise in medicinal chemistry and innovative strategies to tackle complex health issues. His dedication to advancing treatment options has positioned him as a vital player in the company.

Collaborations

Throughout his career, David has collaborated with esteemed professionals, including David D. Thompson. This partnership has fostered an environment of innovative thinking and has propelled research initiatives that aim to address critical medical challenges.

Conclusion

David B. MacLean stands out as a pioneering inventor in hormone therapy, with a clear commitment to enhancing health outcomes through innovation. His contributions to the field and his collaboration with industry experts continue to pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…